Sprint Bioscience AB (publ) (OM: SPRINT)
Health Care · Biotechnology · SE
Skr3.55
-2.74% today · +407.1% 1Y
Sprint Bioscience AB (publ) (OM: SPRINT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $37.82M and employs 32 people.
Over the last twelve months the share price has gained 407.1%, trading between 0.57 and 4.59.
Tweenvest scores Sprint Bioscience AB (publ) across four factors: quality 64/100, value 22/100, growth 100/100. Its strongest factor is growth.
SPRINT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $37.82M
- Revenue (TTM)
- $14.38M
- P/E
- 5.02
- EPS
- 0.71
- Dividend yield
- —
- Beta (5Y)
- -0.57
- 52-week high
- Skr4.59
- 52-week low
- Skr0.57
- Avg volume (3M)
- —
- Shares outstanding
- 105.52M
- Employees
- 32
- Next earnings
- —
About Sprint Bioscience AB (publ)
Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases. The company was incorporated in 2009 and is based in Huddinge, Sweden.
- ISIN
- SE0006343745
- Founded
- 2009
- Listed since
- Nov 7, 2014
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TMS Co., Ltd.TSE: 4891 | $38.44M | ¥132.00 | +0.76% |
| J2KBIO Co., Ltd.KOSDAQ: A420570 | $38.16M | ₩8,700.00 | -8.52% |
| eXoZymes, Inc.NasdaqCM: EXOZ | $37.96M | $4.09 | -22.10% |
| BrightPath Biotherapeutics Co., Ltd.TSE: 4594 | $37.83M | ¥43.00 | -4.44% |
| Novacyt S.A.ENXTPA: ALNOV | $37.63M | €0.46 | +1.20% |
| Cantargia AB (publ)OM: CANTA | $37.18M | Skr1.31 | -4.67% |
| NeoCore Technology Co., Ltd.TPEX: 4131 | $37.10M | NT$30.20 | -3.21% |
| Enimmune CorporationTPEX: 6564 | $36.35M | NT$16.35 | -0.61% |
Figures last refreshed Oct 18, 2026.